MEA Fat Reduction Market - Industry Trends and Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION 210

• 1.1 OBJECTIVES OF THE STUDY 210
• 1.2 MARKET DEFINITION 210
• 1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA FAT REDUCTION MARKET 210
• 1.4 CURRENCY AND PRICING 212
• 1.5 LIMITATIONS 212
• 1.6 MARKETS COVERED 213

2 MARKET SEGMENTATION 218

• 2.1 MARKETS COVERED 218
• 2.2 GEOGRAPHICAL SCOPE 219
• 2.3 YEARS CONSIDERED FOR THE STUDY 220
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 221
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 224
• 2.6 MULTIVARIATE MODELLING 225
• 2.7 TYPE LIFELINE CURVE 225
• 2.8 DBMR MARKET POSITION GRID 226
• 2.9 VENDOR SHARE ANALYSIS 227
• 2.10 MARKET APPLICATION COVERAGE GRID 228
• 2.11 SECONDARY SOURCES 229
• 2.12 ASSUMPTIONS 229

3 EXECUTIVE SUMMARY 230

4 PREMIUM INSIGHT 234

• 4.1 PESTEL ANALYSIS 236
• 4.2 PORTER'S FIVE FORCES 237
• 4.3 MARKET ANALYSIS 238
• 4.4 MIDDLE EAST & AFRICA (PRICING AND PROCEDURE ANALYSIS) 239
  • 4.4.1 SAUDI ARABIA 239
  • 4.4.2 EGYPT 240
  • 4.4.3 UAE 241
  • 4.4.4 SOUTH AFRICA 242
  • 4.4.5 ISRAEL 243
  • 4.4.6 KUWAIT 244
  • 4.4.7 QATAR 245
  • 4.4.8 OMAN 246
  • 4.4.9 BAHRAIN 247
  • 4.4.10 LEBANON 248
  • 4.4.11 ALGERIA 249
  • 4.4.12 JORDAN 250
  • 4.4.13 MOROCCO 251
  • 4.4.14 IRAN 252
  • 4.4.15 LIBIYA 253
  • 4.4.16 IRAQ 254
  • 4.4.17 TUNISIA 255
• 4.5 BRAND ANALYSIS 256
  • 4.5.1 KYBELLA 256
  • 4.5.2 AQUALYX 257
• 4.6 PRICING ANALYSIS (USD) 258
  • 4.6.1 MIDDLE EAST & AFRICA 258
    • 4.6.1.1 SAUDI ARABIA 258
    • 4.6.1.2 EGYPT 258
    • 4.6.1.3 UAE 258
    • 4.6.1.4 SOUTH AFRICA 259
    • 4.6.1.5 ISRAEL 259
    • 4.6.1.6 KUWAIT 259
    • 4.6.1.7 QATAR 260
    • 4.6.1.8 OMAN 260
    • 4.6.1.9 BAHRAIN 260
    • 4.6.1.10 LEBANON 260
    • 4.6.1.11 ALGERIA 261
    • 4.6.1.12 JORDAN 261
    • 4.6.1.13 MOROCCO 261
    • 4.6.1.14 IRAN 261
    • 4.6.1.15 LIBIYA 262
    • 4.6.1.16 IRAQ 262
    • 4.6.1.17 TUNISIA 262
• 4.7 PATENT ANALYSIS OF THE MIDDLE EAST & AFRICA FAT REDUCTION MARKET 263
• 4.8 PRICING ANALYSIS (USD) 264
  • 4.8.1 KYBELLA 264
  • 4.8.2 COOLSCULPTING 266
  • 4.8.3 COOLSCULPTING ELITE 268
  • 4.8.4 COOLTONE 270

5 INDUSTRY INSIGHTS: 273

• 5.1 DEMOGRAPHIC TRENDS: 274
• 5.2 CONCLUSION: 275

6 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, REGULATIONS 276

• 6.1 SOUTH AFRICA 276
  • 6.1.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 276
  • 6.1.2 REGULATORY APPROVAL AGENCIES 276
  • 6.1.3 LICENSING AND REGISTRATION 276
  • 6.1.4 POST-MARKETING SURVEILLANCE 277
• 6.2 SAUDI ARABIA 277
  • 6.2.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 277
  • 6.2.2 REGULATORY APPROVAL AGENCIES 278
  • 6.2.3 LICENSING AND REGISTRATION 278
  • 6.2.4 POST-MARKETING SURVEILLANCE 278
  • 6.2.5 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES 278
• 6.3 UAE 279
  • 6.3.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 279
  • 6.3.2 LICENSING AND REGISTRATION 280
  • 6.3.3 REGULATORY APPROVAL AGENCIES 281
  • 6.3.4 GOOD MANUFACTURING PRACTICES (GMPS) 281
• 6.4 EGYPT 281
  • 6.4.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 281
  • 6.4.2 REGULATORY APPROVAL AGENCIES 282
  • 6.4.3 LICENSING AND REGISTRATION 282
  • 6.4.4 POST-MARKETING SURVEILLANCE 282
  • 6.4.5 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES 282
• 6.5 KUWAIT 282
  • 6.5.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 282
  • 6.5.2 REGULATORY APPROVAL AGENCIES 283
  • 6.5.3 LICENSING AND REGISTRATION 283
• 6.6 ISRAEL 283
  • 6.6.1 REGULATORY APPROVAL PROCESS 283
  • 6.6.2 TIMELINE 283
  • 6.6.3 REGULATORY APPROVAL AGENCIES 283
  • 6.6.4 LICENSING AND REGISTRATION 283
  • 6.6.5 POST-MARKETING SURVEILLANCE 284
• 6.7 ALGERIA 285
  • 6.7.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 285
  • 6.7.2 REGULATORY APPROVAL AGENCIES 285
  • 6.7.3 LICENSING AND REGISTRATION 285
• 6.8 JORDAN 285
  • 6.8.1 REGULATORY APPROVAL AGENCIES, PROCESS, PATHWAYS, AND TIMELINE 285
  • 6.8.2 LICENSING AND REGISTRATION 285
  • 6.8.3 POST-MARKETING SURVEILLANCE 285
• 6.9 BAHRAIN 286
  • 6.9.1 LICENSING AND REGISTRATION 286
  • 6.9.2 FUNDAMENTAL GUIDELINES FOR TRACEABILITY IN BAHRAIN 287
• 6.10 IRAQ 287
  • 6.10.1 REGULATORY APPROVAL PROCESS, AGENCIES, FUNCTION 287
• 6.11 IRAN 288
  • 6.11.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 288
  • 6.11.2 REGULATORY APPROVAL AGENCIES 288
  • 6.11.3 LICENSING AND REGISTRATION 289
• 6.12 LEBANON 289
  • 6.12.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 289
  • 6.12.2 REGULATORY APPROVAL AGENCIES 289
  • 6.12.3 LICENSING AND REGISTRATION 289
• 6.13 LIBYA 290
  • 6.13.1 REGULATORY APPROVAL AGENCIES AND FUNCTION 290
• 6.14 MOROCCO 290
  • 6.14.1 REGULATORY APPROVAL AGENCIES AND FUNCTION 290
• 6.15 OMAN 290
  • 6.15.1 REGULATORY APPROVAL AGENCIES AND REGISTRATION PROCESS 290
• 6.16 QATAR 291
  • 6.16.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE 291
  • 6.16.2 REGULATORY APPROVAL AGENCIES 291
• 6.17 TUNISIA 291
  • 6.17.1 REGULATORY APPROVAL AGENCIES AND REGISTRATION PROCESS 291
  • 6.17.2 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES: 293

7 PIPELINE ANALYSIS OF THE MIDDLE EAST & AFRICA FAT REDUCTION MARKET 295

8 MARKET ACCESS 302

• 8.1 MANUFACTURER AND STRATEGIC DEALS 302
• 8.2 CURRENT TREATMENT PRACTICES 302
• 8.3 IMPACT OF UPCOMING THERAPY 303

9 MARKET OVERVIEW 304

• 9.1 DRIVERS 306
  • 9.1.1 INCREASING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES 306
  • 9.1.2 GROWING AESTHETIC CONSCIOUSNESS AND BEAUTY STANDARDS 307
  • 9.1.3 GROWING TECHNOLOGICAL ADVANCEMENTS 308
  • 9.1.4 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES 309
• 9.2 RESTRAINTS 310
  • 9.2.1 HIGH COST OF PROCEDURES 310
  • 9.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES 311
  • 9.2.3 PRODUCT RECALL 311
• 9.3 OPPORTUNITIES 312
  • 9.3.1 CUSTOMIZED TREATMENT PLANS AND INTEGRATION WITH OTHER AESTHETIC PROCEDURES 312
  • 9.3.2 BELIEF AND TREND OF FAT REDUCTION IN YOUNG ADULTS 313
  • 9.3.3 FOCUS ON INCLUSIVITY AND DIVERSITY AND EXPANSION OF PRODUCT LINES 315
• 9.4 CHALLENGES 317
  • 9.4.1 LONG-TERM EFFICACY AND SUSTAINABILITY 317
  • 9.4.2 LONGER RECOVERY TIME OF THE PROCEDURE 317

10 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY TYPE 319

• 10.1 OVERVIEW 320
• 10.2 SURGICAL FAT REDUCTION 323
  • 10.2.1 LIPOSUCTION 324
    • 10.2.1.1 BY TYPE 325
      • 10.2.1.1.1 ULTRASOUND-ASSISTED LIPOSUCTION 325
      • 10.2.1.1.2 LASER-ASSISTED LIPOSUCTION 326
      • 10.2.1.1.3 TUMESCENT LIPOSUCTION 326
      • 10.2.1.1.4 SUPER-WET TECHNIQUE 326
    • 10.2.1.2 BY APPLICATION 326
      • 10.2.1.2.1 ABDOMINAL FAT 327
      • 10.2.1.2.2 THIGHS FAT 327
      • 10.2.1.2.3 BUTTOCK FAT 327
      • 10.2.1.2.4 UPPER-ARM FAT 327
      • 10.2.1.2.5 FACIAL FAT-DEPOSITS 327
      • 10.2.1.2.5.1 SUBMENTAL AREAS 328
      • 10.2.1.2.5.2 MALAR 328
      • 10.2.1.2.5.3 MANDIBULAR 328
      • 10.2.1.2.6 KNEE FAT 328
  • 10.2.2 SURGICAL REJUVENATION 328
    • 10.2.2.1 FACE LIFT 329
    • 10.2.2.2 NECK LIFT 329
  • 10.2.3 CHIN IMPLANT 329
    • 10.2.3.1 SILICONE CHIN IMPLANTS 330
    • 10.2.3.2 OTHERS 330
  • 10.2.4 PORUS IMPLANTS 330
    • 10.2.4.1 TEFLON 331
    • 10.2.4.2 GORE-TEX 331
    • 10.2.4.3 MEDPORE IMPLANTS 331
• 10.3 NON-INVASIVE FAT REDUCTION 331
  • 10.3.1 CRYOLIPOLYSIS 334
    • 10.3.1.1 COOL SCULPTING 334
    • 10.3.1.2 COOL SCULPTING ELITE 334
    • 10.3.1.3 COOL TONE 335
    • 10.3.1.4 OTHERS 335
      • 10.3.1.4.1 ABDOMINAL FAT 335
      • 10.3.1.4.2 THIGHS FAT 335
      • 10.3.1.4.3 BUTTOCK FAT 336
      • 10.3.1.4.4 UPPER-ARM FAT 336
      • 10.3.1.4.5 FACIAL FAT-DEPOSITS 336
      • 10.3.1.4.6 KNEE FAT 336
  • 10.3.2 ULTRASOUND 336
    • 10.3.2.1 INTERNAL ULTRASONIC LIPOSUCTION 337
    • 10.3.2.2 EXTERNAL ULTRASONIC LIPOSUCTION 337
      • 10.3.2.2.1 ABDOMINAL FAT 338
      • 10.3.2.2.2 THIGHS FAT 338
      • 10.3.2.2.3 BUTTOCK FAT 338
      • 10.3.2.2.4 UPPER-ARM FAT 338
      • 10.3.2.2.5 FACIAL FAT-DEPOSITS 338
      • 10.3.2.2.6 KNEE FAT 338
  • 10.3.3 RADIOFREQUENCY 339
    • 10.3.3.1 ABDOMINAL FAT 339
    • 10.3.3.2 THIGHS FAT 339
    • 10.3.3.3 BUTTOCK FAT 339
    • 10.3.3.4 UPPER-ARM FAT 339
    • 10.3.3.5 FACIAL FAT-DEPOSITS 340
    • 10.3.3.6 KNEE FAT 340
  • 10.3.4 LOW LEVEL LASER THERAPY 340
    • 10.3.4.1 ABDOMINAL FAT 340
    • 10.3.4.2 THIGHS FAT 340
    • 10.3.4.3 BUTTOCK FAT 341
    • 10.3.4.4 UPPER-ARM FAT 341
    • 10.3.4.5 FACIAL FAT-DEPOSITS 341
    • 10.3.4.6 KNEE FAT 341
  • 10.3.5 OTHERS 341
• 10.4 MINIMALLY INVASIVE 341
  • 10.4.1 INJECTION LIPOLYSIS 343
    • 10.4.1.1 DEOXYCHOLIC ACID INJECTIONS 343
      • 10.4.1.1.1 KYBELLA/BELKYRA 344
      • 10.4.1.1.1.1 FACIAL FAT-DEPOSITS 345
      • 10.4.1.1.1.2 UPPER-ARM FAT 345
      • 10.4.1.1.1.3 ABDOMINAL FAT 345
      • 10.4.1.1.1.4 THIGHS FAT 345
      • 10.4.1.1.1.5 KNEE FAT 345
      • 10.4.1.1.1.6 BUTTOCK FAT 345
      • 10.4.1.1.2 AQUALYX 346
      • 10.4.1.1.2.1 FACIAL FAT-DEPOSITS 346
      • 10.4.1.1.2.2 UPPER-ARM FAT 346
      • 10.4.1.1.2.3 ABDOMINAL FAT 346
      • 10.4.1.1.2.4 THIGHS FAT 347
      • 10.4.1.1.2.5 KNEE FAT 347
      • 10.4.1.1.2.6 BUTTOCK FAT 347
    • 10.4.1.2 PHOSPHATIDYLCHOLINE 347
      • 10.4.1.2.1 FACIAL FAT-DEPOSITS 348
      • 10.4.1.2.2 UPPER-ARM FAT 348
      • 10.4.1.2.3 ABDOMINAL FAT 348
      • 10.4.1.2.4 THIGHS FAT 348
      • 10.4.1.2.5 KNEE FAT 348
      • 10.4.1.2.6 BUTTOCK FAT 348
    • 10.4.1.3 OTHERS 348
  • 10.4.2 OTHERS 348

11 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY APPLICATION 349

• 11.1 OVERVIEW 350
• 11.2 ABDOMINAL FAT 353
• 11.3 THIGHS FAT 354
• 11.4 BUTTOCK FAT 355
• 11.5 UPPER-ARM FAT 356
• 11.6 FACIAL FAT-DEPOSITS 357
  • 11.6.1 SUBMENTAL AREAS 358
  • 11.6.2 MANDIBULAR 358
  • 11.6.3 MALAR 358
• 11.7 KNEE FAT 358

12 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY GENDER 360

• 12.1 OVERVIEW 361
• 12.2 FEMALE 364
• 12.3 MALE 365

13 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY AGE GROUP 366

• 13.1 OVERVIEW 367
• 13.2 ADULT 370
• 13.3 GERIATRIC 371
• 13.4 CHILD 372

14 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY END USER 374

• 14.1 OVERVIEW 375
• 14.2 HOSPITALS 378
  • 14.2.1 BY TYPE 379
    • 14.2.1.1 PRIVATE 379
    • 14.2.1.2 PUBLIC 379
  • 14.2.2 BY CATEGORY 379
    • 14.2.2.1 TIER 1 380
    • 14.2.2.2 TIER 2 380
    • 14.2.2.3 TIER 3 380
• 14.3 MULTISPECIALTY CLINICS 380
• 14.4 DERMATOLOGY CENTERS 381
• 14.5 MEDICAL SPAS AND BEAUTY CENTERS 382
• 14.6 OTHERS 383

15 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL 385

• 15.1 OVERVIEW 386
• 15.2 DIRECT TENDERS 389
• 15.3 RETAIL SALES 390
• 15.4 THIRD PARTY DISTRIBUTORS 391
• 15.5 OTHERS 392

16 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY REGION 393

• 16.1 MIDDLE EAST AND AFRICA 394
  • 16.1.1 SAUDI ARABIA 413
  • 16.1.2 EGYPT 429
  • 16.1.3 U.A.E. 445
  • 16.1.4 SOUTH AFRICA 462
  • 16.1.5 ISRAEL 478
  • 16.1.6 KUWAIT 493
  • 16.1.7 QATAR 510
  • 16.1.8 OMAN 526
  • 16.1.9 BAHRAIN 542
  • 16.1.10 LEBANON 558
  • 16.1.11 ALGERIA 575
  • 16.1.12 JORDAN 592
  • 16.1.13 MOROCCO 609
  • 16.1.14 IRAN 626
  • 16.1.15 LIBIYA 642
  • 16.1.16 IRAQ 658
  • 16.1.17 TUNISIA 675
  • 16.1.18 REST OF MIDDLE EAST AND AFRICA 691

17 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, COMPANY LANDSCAPE 693

• 17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 693

18 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, COMPANY LANDSCAPE COUNTRY WISE 694

• 18.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 694
  • 18.1.1 COMPANY SHARE ANALYSIS: SOUTH AFRICA 694
    • 18.1.1.1 ABBVIE INC. 695
    • 18.1.1.2 CANDELA CORPORATION 696
  • 18.1.2 COMPANY SHARE ANALYSIS: SAUDI ARABIA 697
    • 18.1.2.1 COMPANY SHARE ANALYSIS: SAUDI ARABIA 697
    • 18.1.2.2 ABBVIE INC. 698
    • 18.1.2.3 CANDELA CORPORATION 699
    • 18.1.2.4 ERCHONIA CORPORATION 700
  • 18.1.3 COMPANY SHARE ANALYSIS: UAE 701
    • 18.1.3.1 COMPANY SHARE ANALYSIS: UAE 701
    • 18.1.3.2 ABBVIE INC. 702
    • 18.1.3.3 CANDELA CORPORATION 703
  • 18.1.4 COMPANY SHARE ANALYSIS: EGYPT 704
    • 18.1.4.1 COMPANY SHARE ANALYSIS: EGYPT 704
    • 18.1.4.2 CANDELA CORPORATION 705
    • 18.1.4.3 BLACK & BLACK SURGICAL 706
  • 18.1.5 COMPANY SHARE ANALYSIS: KUWAIT 707
    • 18.1.5.1 COMPANY SHARE ANALYSIS: KUWAIT 707
    • 18.1.5.2 CANDELA CORPORATION 708
    • 18.1.5.3 BLACK & BLACK SURGICAL 709
  • 18.1.6 COMPANY SHARE ANALYSIS: ISRAEL 710
    • 18.1.6.1 COMPANY SHARE ANALYSIS: ISRAEL 710
    • 18.1.6.2 ABBVIE INC. 711
    • 18.1.6.3 ALMA LASERS 712
    • 18.1.6.4 CANDELA CORPORATION 713
    • 18.1.6.5 VENUS CONCEPT 714
  • 18.1.7 COMPANY SHARE ANALYSIS: ALGERIA 715
    • 18.1.7.1 COMPANY SHARE ANALYSIS: ALERGIA 715
    • 18.1.7.2 ABBVIE INC. 716
  • 18.1.8 COMPANY SHARE ANALYSIS: JORDAN 717
    • 18.1.8.1 COMPANY SHARE ANALYSIS: JORDAN 717
    • 18.1.8.2 CANDELA CORPORATION 718
  • 18.1.9 COMPANY SHARE ANALYSIS: BAHRAIN 719
    • 18.1.9.1 COMPANY SHARE ANALYSIS: BAHRAIN 719
    • 18.1.9.2 LYNTON LASERS 720
    • 18.1.9.3 BLACK & BLACK SURGICAL 721
  • 18.1.10 COMPANY SHARE ANALYSIS: IRAN 722
    • 18.1.10.1 COMPANY SHARE ANALYSIS: IRAN 722
    • 18.1.10.2 CANDELA CORPORATION 723
    • 18.1.10.3 HIRONIC CO LTD 724
  • 18.1.11 COMPANY SHARE ANALYSIS: IRAQ 725
    • 18.1.11.1 COMPANY SHARE ANALYSIS: IRAQ 725
    • 18.1.11.2 CANDELA CORPORATION 726
    • 18.1.11.3 BLACK & BLACK SURGICAL 727
    • 18.1.11.4 HIRONIC CO LTD 728
  • 18.1.12 COMPANY SHARE ANALYSIS: LEBANON 729
    • 18.1.12.1 COMPANY SHARE ANALYSIS: LEBANON 729
    • 18.1.12.2 ABBVIE INC. 730
    • 18.1.12.3 HIRONIC CO LTD 731
  • 18.1.13 COMPANY SHARE ANALYSIS: LIBIYA 732
    • 18.1.13.1 COMPANY SHARE ANALYSIS: LIBIYA 732
    • 18.1.13.2 ADVIN HEALTH CARE 733
  • 18.1.14 COMPANY SHARE ANALYSIS: MOROCCO 734
    • 18.1.14.1 COMPANY SHARE ANALYSIS: MOROCCO 734
    • 18.1.14.2 ADVIN HEALTH CARE 735
  • 18.1.15 COMPANY SHARE ANALYSIS: OMAN 736
    • 18.1.15.1 COMPANY SHARE ANALYSIS: OMAN 736
    • 18.1.15.2 CANDELA CORPORATION 737
    • 18.1.15.3 BLACK & BLACK SURGICAL 738
  • 18.1.16 COMPANY SHARE ANALYSIS: QATAR 739
    • 18.1.16.1 COMPANY SHARE ANALYSIS: QATAR 739
    • 18.1.16.2 CANDELA CORPORATION 740
    • 18.1.16.3 BLACK & BLACK SURGICAL 741
  • 18.1.17 COMPANY SHARE ANALYSIS: TUNISIA 742
    • 18.1.17.1 COMPANY SHARE ANALYSIS: TUNISIA 742
    • 18.1.17.2 ABBVIE INC. 743

19 SWOT ANALYSIS 744

20 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, COMPANY PROFILINGS 745

• 20.1 ABBVIE INC.(2022) 745
  • 20.1.1 COMPANY SNAPSHOT 745
  • 20.1.2 REVENUE ANALYSIS 745
  • 20.1.3 COMPANY SHARE ANALYSIS 746
  • 20.1.4 PRODUCT PORTFOLIO 746
  • 20.1.5 RECENT DEVELOPMENTS 747
• 20.2 CYNOSURE 748
  • 20.2.1 COMPANY SNAPSHOT 748
  • 20.2.2 COMPANY SHARE ANALYSIS 748
  • 20.2.3 PRODUCT PORTFOLIO 749
  • 20.2.4 RECENT DEVELOPMENTS 749
• 20.3 ALMA LASERS 750
  • 20.3.1 COMPANY SNAPSHOT 750
  • 20.3.2 COMPANY SHARE ANALYSIS 750
  • 20.3.3 PRODUCT PORTFOLIO 751
  • 20.3.4 RECENT DEVELOPMENT 751
• 20.4 CANDELA CORPORATION 752
  • 20.4.1 COMPANY SNAPSHOT 752
  • 20.4.2 COMPANY SHARE ANALYSIS 752
  • 20.4.3 PRODUCT PORTFOLIO 753
  • 20.4.4 RECENT DEVELOPMENT 753
• 20.5 MERZ NORTH AMERICA, INC. 754
  • 20.5.1 COMPANY SNAPSHOT 754
  • 20.5.2 COMPANY SHARE ANALYSIS 754
  • 20.5.3 PRODUCT PORTFOLIO 755
  • 20.5.4 RECENT DEVELOPMENTS 755
• 20.6 3D AESTHETICS 756
  • 20.6.1 COMPANY SNAPSHOT 756
  • 20.6.2 PRODUCT PORTFOLIO 756
  • 20.6.3 RECENT DEVELOPMENT 756
• 20.7 ADVIN HEALTH CARE 757
  • 20.7.1 COMPANY SNAPSHOT 757
  • 20.7.2 PRODUCT PORTFOLIO 757
  • 20.7.3 RECENT DEVELOPMENT 757
• 20.8 BLACK & BLACK SURGICAL 758
  • 20.8.1 COMPANY SNAPSHOT 758
  • 20.8.2 PRODUCT PORTFOLIO 758
  • 20.8.3 RECENT DEVELOPMENT 758
• 20.9 BTL GROUP OF COMPANIES 759
  • 20.9.1 COMPANY SNAPSHOT 759
  • 20.9.2 PRODUCT PORTFOLIO 759
  • 20.9.3 RECENT DEVELOPMENTS 759
• 20.10 BAUSCH HEALTH COMPANIES INC. 760
  • 20.10.1 COMPANY SNAPSHOT 760
  • 20.10.2 REVENUE ANALYSIS 760
  • 20.10.3 PRODUCT PORTFOLIO 761
  • 20.10.4 RECENT DEVELOPMENT 761
• 20.11 CUTERA (2022) 762
  • 20.11.1 COMPANY SNAPSHOT 762
  • 20.11.2 REVENUE ANALYSIS 762
  • 20.11.3 PRODUCT PORTFOLIO 763
  • 20.11.4 RECENT DEVELOPMENT 763
• 20.12 DEXLEVOAESTHETIC 764
  • 20.12.1 COMPANY SNAPSHOT 764
  • 20.12.2 PRODUCT PORTFOLIO 764
  • 20.12.3 RECENT DEVELOPMENT 764
• 20.13 ERCHONIA CORPORATION 765
  • 20.13.1 COMPANY SNAPSHOT 765
  • 20.13.2 PRODUCT PORTFOLIO 765
  • 20.13.3 RECENT DEVELOPMENT 765
• 20.14 FOTONA 766
  • 20.14.1 COMPANY SNAPSHOT 766
  • 20.14.2 PRODUCT PORTFOLIO 766
  • 20.14.3 RECENT DEVELOPMENT 766
• 20.15 GENESIS BIOSYSTEMS, INC. 767
  • 20.15.1 COMPANY SNAPSHOT 767
  • 20.15.2 PRODUCT PORTFOLIO 767
  • 20.15.3 RECENT DEVELOPMENT 767
• 20.16 HIRONIC CO., LTD. 768
  • 20.16.1 COMPANY SNAPSHOT 768
  • 20.16.2 REVENUE ANALYSIS 768
  • 20.16.3 PRODUCT PORTFOLIO 769
  • 20.16.4 RECENT DEVELOPMENT 769
• 20.17 IMPLANTECH 770
  • 20.17.1 COMPANY SNAPSHOT 770
  • 20.17.2 PRODUCT PORTFOLIO 770
  • 20.17.3 RECENT DEVELOPMENTS 771
• 20.18 INTROPHARMA 772
  • 20.18.1 COMPANY SNAPSHOT 772
  • 20.18.2 PRODUCT PORTFOLIO 772
  • 20.18.3 RECENT DEVELOPMENT 772
• 20.19 LEADERMA INC. 773
  • 20.19.1 COMPANY SNAPSHOT 773
  • 20.19.2 PRODUCT PORTFOLIO 773
  • 20.19.3 RECENT DEVELOPMENT 773
• 20.20 LYNTON LASERS LTD 774
  • 20.20.1 COMPANY SNAPSHOT 774
  • 20.20.2 PRODUCT PORTFOLIO 774
  • 20.20.3 RECENT DEVELOPMENT 774
• 20.21 MENTOR WORLDWIDE LLC (A PART OF JOHNSON & JOHNSON SERVICES, INC.) 775
  • 20.21.1 COMPANY SNAPSHOT 775
  • 20.21.2 REVENUE ANALYSIS 775
  • 20.21.3 PRODUCT PORTFOLIO 776
  • 20.21.4 RECENT DEVELOPMENT 776
• 20.22 MICROAIRE SURGICAL INSTRUMENTS, LLC. 777
  • 20.22.1 COMPANY SNAPSHOT 777
  • 20.22.2 PRODUCT PORTFOLIO 777
  • 20.22.3 RECENT DEVELOPMENT 777
• 20.23 MOLLER MEDICAL 778
  • 20.23.1 COMPANY SNAPSHOT 778
  • 20.23.2 PRODUCT PORTFOLIO 778
  • 20.23.3 RECENT DEVELOPMENT 778
• 20.24 POLLOGEN (A SUBSIDIARY OF LUMENIS BE LTD.) 779
  • 20.24.1 COMPANY SNAPSHOT 779
  • 20.24.2 PRODUCT PORTFOLIO 779
  • 20.24.3 RECENT DEVELOPMENT 779
• 20.25 SILIMED 780
  • 20.25.1 COMPANY SNAPSHOT 780
  • 20.25.2 PRODUCT PORTFOLIO 780
  • 20.25.3 RECENT DEVELOPMENTS 780
• 20.26 SURGIFORM INNOVATIVE SURGICAL PRODUCTS 781
  • 20.26.1 COMPANY SNAPSHOT 781
  • 20.26.2 PRODUCT PORTFOLIO 781
  • 20.26.3 RECENT DEVELOPMENT 781
• 20.27 VENUS CONCEPT 782
  • 20.27.1 COMPANY SNAPSHOT 782
  • 20.27.2 REVENUE ANALYSIS 782
  • 20.27.3 PRODUCT PORTFOLIO 783
  • 20.27.4 RECENT DEVELOPMENT 783

21 QUESTIONNAIRE 784

22 RELATED REPORTS 788

LIST OF TABLES

• TABLE 1 NUMBER OF PROCEDURES AND AVERAGE COST OF PROCEDURES 102
• TABLE 2 NUMBER OF PROCEDURES AND AVERAGE COST OF PROCEDURES 103
• TABLE 3 NUMBER OF PROCEDURES AND AVERAGE COST OF PROCEDURES 104
• TABLE 4 NUMBER OF PROCEDURES AND AVERAGE COST OF PROCEDURES 105
• TABLE 5 NUMBER OF PROCEDURES AND AVERAGE COST OF PROCEDURES 106
• TABLE 6 NUMBER OF PROCEDURES AND AVERAGE COST OF PROCEDURES 107
• TABLE 7 NUMBER OF PROCEDURES AND AVERAGE COST OF PROCEDURES 108
• TABLE 8 NUMBER OF PROCEDURES AND AVERAGE COST OF PROCEDURES 115
• TABLE 9 NUMBER OF PROCEDURES AND AVERAGE COST OF PROCEDURES 116
• TABLE 10 NUMBER OF PROCEDURES AND AVERAGE COST OF PROCEDURES 117
• TABLE 11 NUMBER OF PROCEDURES AND AVERAGE COST OF PROCEDURES 118
• TABLE 12 AVERAGE SELLING PRICE, SALES, NUMBER OF UNIT SOLD 121
• TABLE 13 AVERAGE SELLING PRICE, SALES, NUMBER OF UNIT SOLD 121
• TABLE 14 AVERAGE SELLING PRICE, SALES, NUMBER OF UNIT SOLD 121
• TABLE 15 AVERAGE SELLING PRICE, SALES, NUMBER OF UNIT SOLD 122
• TABLE 16 AVERAGE SELLING PRICE, SALES, NUMBER OF UNIT SOLD 122
• TABLE 17 AVERAGE SELLING PRICE, SALES, NUMBER OF UNIT SOLD 122
• TABLE 18 AVERAGE SELLING PRICE, SALES, NUMBER OF UNIT SOLD 123
• TABLE 19 AVERAGE SELLING PRICE, SALES, NUMBER OF UNIT SOLD 124
• TABLE 20 AVERAGE SELLING PRICE, SALES, NUMBER OF UNIT SOLD 125
• TABLE 21 AVERAGE SELLING PRICE, SALES, NUMBER OF UNIT SOLD 125
• TABLE 22 AVERAGE SELLING PRICE, SALES, NUMBER OF UNIT SOLD 125
• TABLE 23 EVALUATION OF SAFETY AND EFFICACY OF RZL-012 IN SUBJECTS SEEKING FAT REDUCTION IN THE FLANKS 158
• TABLE 24 AN OPEN LABEL STUDY THAT WILL TEST SAFETY AND EFFICACY OF RZL-012 INJECTION INTO THE SUBMENTAL FAT IN 10 CHINESE VS. 10 NON-CHINESE SUBJECTS. 158
• TABLE 25 EVALUATE THE EFFICACY AND SAFETY OF POLYENE PHOSPHATIDYLCHOLINE INJECTION (AYP-101) FOR THE REDUCTION OF SUBMENTAL FAT (AYP-101) 159
• TABLE 26 A STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF CBL-514 INJECTION FOR REDUCING ABDOMINAL SUBCUTANEOUS FAT 159
• TABLE 27 DETERMINE THE DOSING INTERVAL AND OPTIMAL DOSE OF AYP-101 FOR THE REDUCTION OF SUBMENTAL FAT IN CHIN AREA 160
• TABLE 28 SAFETY AND EFFICACY OF DEOXYCHOLIC ACID INJECTION FOR REDUCTION OF UPPER INNER THIGH FAT 160
• TABLE 29 DEOXYCHOLIC ACID INJECTION FOR THE TREATMENT OF SUPERFICIAL LIPOMAS 160
• TABLE 30 EVALUATION OF SAFETY AND EFFICACY OF DEOXYCHOLIC ACID INJECTION (ATX-101) IN THE REDUCTION OF SUBMENTAL FAT 161
• TABLE 31 LIPID AND ADIPOKINE PROFILES FOLLOWING SUBCUTANEOUS INJECTION OF ATX-101 INTO ABDOMINAL FAT TISSUE 161
• TABLE 32 DEOXYCHOLIC ACID INJECTION SUBMENTAL FAT (SMF) MAGNETIC RESONANCE IMAGING (MRI) AND SUBJECT-REPORTED OUTCOME MEASURES STUDY 162
• TABLE 33 PATIENT EXPERIENCE STUDY OF DEOXYCHOLIC ACID INJECTION 162
• TABLE 34 STUDY OF DEOXYCHOLIC ACID INJECTION (ATX-101) VERSUS PLACEBO FOR THE REDUCTION OF LOCALIZED SUBCUTANEOUS FAT IN THE SUBMENTAL AREA 162
• TABLE 35 LONG-TERM FOLLOW-UP STUDY ON SAFETY AND MAINTENANCE OF EFFICACY OF ATX-101 163
• TABLE 36 SAFETY STUDY OF DEOXYCHOLIC ACID FOR THE REDUCTION OF LOCALIZED SUBCUTANEOUS FAT IN THE SUBMENTAL AREA IN SUBJECTS 65 TO 75 YEARS OF AGE 163
• TABLE 37 SAFETY STUDY OF ATX-101 (DEOXYCHOLIC ACID) IN SUBJECTS WITH MILD OR EXTREME FULLNESS OF SUBMENTAL FAT 164
• TABLE 38 OPEN-LABEL STUDY OF DEOXYCHOLIC ACID FOR THE REDUCTION OF LOCALIZED SUBCUTANEOUS FAT IN THE SUBMENTAL AREA 164
• TABLE 39 AVERAGE COST OF LIPOSUCTION ACROSS THE U.S. 173
• TABLE 40 AVERAGE COSTS OF CHIN AUGMENTATION ACROSS THE U.S. 173
• TABLE 41 COST OF LIPOSUCTION IN SOME EUROPEAN COUNTRIES 174
• TABLE 42 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 185
• TABLE 43 MIDDLE EAST & AFRICA SURGICAL FAT REDUTCION IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 186
• TABLE 44 MIDDLE EAST & AFRICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 187
• TABLE 45 MIDDLE EAST & AFRICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 188
• TABLE 46 MIDDLE EAST & AFRICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 188
• TABLE 47 MIDDLE EAST & AFRICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 189
• TABLE 48 MIDDLE EAST & AFRICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 190
• TABLE 49 MIDDLE EAST & AFRICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 191
• TABLE 50 MIDDLE EAST & AFRICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 192
• TABLE 51 MIDDLE EAST & AFRICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION) 192
• TABLE 52 MIDDLE EAST & AFRICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES) 193
• TABLE 53 MIDDLE EAST & AFRICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 193
• TABLE 54 MIDDLE EAST & AFRICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 194
• TABLE 55 MIDDLE EAST & AFRICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 195
• TABLE 56 MIDDLE EAST & AFRICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 196
• TABLE 57 MIDDLE EAST & AFRICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 196
• TABLE 58 MIDDLE EAST & AFRICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 197
• TABLE 59 MIDDLE EAST & AFRICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 197
• TABLE 60 MIDDLE EAST & AFRICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 198
• TABLE 61 MIDDLE EAST & AFRICA ULTRASOUND IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 199
• TABLE 62 MIDDLE EAST & AFRICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 200
• TABLE 63 MIDDLE EAST & AFRICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 200
• TABLE 64 MIDDLE EAST & AFRICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 202
• TABLE 65 MIDDLE EAST & AFRICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 203
• TABLE 66 MIDDLE EAST & AFRICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 205
• TABLE 67 MIDDLE EAST & AFRICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 205
• TABLE 68 MIDDLE EAST & AFRICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 206
• TABLE 69 MIDDLE EAST & AFRICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 206
• TABLE 70 MIDDLE EAST & AFRICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION) 207
• TABLE 71 MIDDLE EAST & AFRICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES) 207
• TABLE 72 MIDDLE EAST & AFRICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 207
• TABLE 73 MIDDLE EAST & AFRICA AQUALYX IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 209
• TABLE 74 MIDDLE EAST & AFRICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 210
• TABLE 75 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 215
• TABLE 76 MIDDLE EAST & AFRICA ABDOMINAL FAT IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 216
• TABLE 77 MIDDLE EAST & AFRICA THIGHS FAT IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 217
• TABLE 78 MIDDLE EAST & AFRICA BUTTOCK FAT IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION)) 218
• TABLE 79 MIDDLE EAST & AFRICA UPPER-ARM FAT IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 219
• TABLE 80 MIDDLE EAST & AFRICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 220
• TABLE 81 MIDDLE EAST & AFRICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 221
• TABLE 82 MIDDLE EAST & AFRICA KNEE FAT IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 222
• TABLE 83 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION) 226
• TABLE 84 MIDDLE EAST & AFRICA FEMALE IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 227
• TABLE 85 MIDDLE EAST & AFRICA MALE IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 228
• TABLE 86 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION) 232
• TABLE 87 MIDDLE EAST & AFRICA ADULT IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 234
• TABLE 88 MIDDLE EAST & AFRICA GERIATRIC IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 235
• TABLE 89 MIDDLE EAST & AFRICA CHILD IN FAT REDUCTION MARKET, BY REGION, 2021-2033 (USD MILLION) 236
• TABLE 90 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION) 240
• TABLE 91 MIDDLE EAST & AFRICA HOSPITALS IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 241
• TABLE 92 MIDDLE EAST & AFRICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 242
• TABLE 93 MIDDLE EAST & AFRICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION) 242
• TABLE 94 MIDDLE EAST & AFRICA MULTISPECIALITY CLINICS IN FAT REDUCTION MARKET, 2019-2033 (USD MILLION) 244
• TABLE 95 MIDDLE EAST & AFRICA HOSPITALS IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 245
• TABLE 96 MIDDLE EAST & AFRICA MEDICAL SPAS AND BEAUTY CENTERS IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 246
• TABLE 97 MIDDLE EAST & AFRICA OTHERS IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 247
• TABLE 98 MIDDLE EAST & AFRICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION) 251
• TABLE 99 MIDDLE EAST & AFRICA DIRECT TENDERS IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 252
• TABLE 100 MIDDLE EAST & AFRICA RETAIL SALES IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 253
• TABLE 101 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTORS IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 254
• TABLE 102 MIDDLE EAST & AFRICA OTHERS IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION) 255
• TABLE 103 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 261
• TABLE 104 MIDDLE EAST AND AFRICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 261
• TABLE 105 MIDDLE EAST AND AFRICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 262
• TABLE 106 MIDDLE EAST AND AFRICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 262
• TABLE 107 MIDDLE EAST AND AFRICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 263
• TABLE 108 MIDDLE EAST AND AFRICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 263
• TABLE 109 MIDDLE EAST AND AFRICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 263
• TABLE 110 MIDDLE EAST AND AFRICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 264
• TABLE 111 MIDDLE EAST AND AFRICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION) 264
• TABLE 112 MIDDLE EAST AND AFRICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES) 264
• TABLE 113 MIDDLE EAST AND AFRICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 264
• TABLE 114 MIDDLE EAST AND AFRICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 265
• TABLE 115 MIDDLE EAST AND AFRICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 265
• TABLE 116 MIDDLE EAST AND AFRICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 265
• TABLE 117 MIDDLE EAST AND AFRICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 266
• TABLE 118 MIDDLE EAST AND AFRICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 266
• TABLE 119 MIDDLE EAST AND AFRICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 266
• TABLE 120 MIDDLE EAST AND AFRICAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 267
• TABLE 121 MIDDLE EAST AND AFRICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 267
• TABLE 122 MIDDLE EAST AND AFRICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 267
• TABLE 123 MIDDLE EAST AND AFRICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 268
• TABLE 124 MIDDLE EAST AND AFRICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 269
• TABLE 125 MIDDLE EAST AND AFRICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 269
• TABLE 126 MIDDLE EAST AND AFRICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 270
• TABLE 127 MIDDLE EAST AND AFRICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 270
• TABLE 128 MIDDLE EAST AND AFRICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION) 270
• TABLE 129 MIDDLE EAST AND AFRICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES) 270
• TABLE 130 MIDDLE EAST AND AFRICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 271
• TABLE 131 MIDDLE EAST AND AFRICA AQUALYX IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 271
• TABLE 132 MIDDLE EAST AND AFRICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 272
• TABLE 133 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 272
• TABLE 134 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES) 273
• TABLE 135 MIDDLE EAST AND AFRICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 273
• TABLE 136 MIDDLE EAST AND AFRICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES) 273
• TABLE 137 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION) 274
• TABLE 138 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION) 274
• TABLE 139 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION) 274
• TABLE 140 MIDDLE EAST AND AFRICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 275
• TABLE 141 MIDDLE EAST AND AFRICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION) 275
• TABLE 142 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION) 275
• TABLE 143 SAUDI ARABIA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 276
• TABLE 144 SAUDI ARABIA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 276
• TABLE 145 SAUDI ARABIA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 276
• TABLE 146 SAUDI ARABIA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 277
• TABLE 147 SAUDI ARABIA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (ASP) 277
• TABLE 148 SAUDI ARABIA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 277
• TABLE 149 SAUDI ARABIA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 278
• TABLE 150 SAUDI ARABIA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 278
• TABLE 151 SAUDI ARABIA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 278
• TABLE 152 SAUDI ARABIA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (ASP) 278
• TABLE 153 SAUDI ARABIA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION) 279
• TABLE 154 SAUDI ARABIA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES) 279
• TABLE 155 SAUDI ARABIA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (ASP) 279
• TABLE 156 SAUDI ARABIA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 279
• TABLE 157 SAUDI ARABIA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 280
• TABLE 158 SAUDI ARABIA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (ASP) 280
• TABLE 159 SAUDI ARABIA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 280
• TABLE 160 SAUDI ARABIA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 280
• TABLE 161 SAUDI ARABIA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (ASP) 281
• TABLE 162 SAUDI ARABIA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 281
• TABLE 163 SAUDI ARABIA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 281
• TABLE 164 SAUDI ARABIA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (ASP) 282
• TABLE 165 SAUDI ARABIA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 282
• TABLE 166 SAUDI ARABIAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 282
• TABLE 167 SAUDI ARABIA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 283
• TABLE 168 SAUDI ARABIA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (ASP) 283
• TABLE 169 SAUDI ARABIA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 283
• TABLE 170 SAUDI ARABIA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 284
• TABLE 171 SAUDI ARABIA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION) 284
• TABLE 172 SAUDI ARABIA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 285
• TABLE 173 SAUDI ARABIA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION) 285
• TABLE 174 SAUDI ARABIA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES) 285
• TABLE 175 SAUDI ARABIA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (ASP) 285

LIST OF FIGURES

• FIGURE 1 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: SEGMENTATION 73
• FIGURE 2 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: DATA TRIANGULATION 76
• FIGURE 3 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: DROC ANALYSIS 77
• FIGURE 4 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: MIDDLE EAST & AFRICA VS. REGIONAL MARKET ANALYSIS 78
• FIGURE 5 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: COMPANY RESEARCH ANALYSIS 78
• FIGURE 6 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: INTERVIEW DEMOGRAPHICS 79
• FIGURE 7 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: MULTIVARIATE MODELLING 80
• FIGURE 8 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: DBMR MARKET POSITION GRID 81
• FIGURE 9 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: VENDOR SHARE ANALYSIS 82
• FIGURE 10 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: MARKET APPLICATION COVERAGE GRID 83
• FIGURE 11 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: SEGMENTATION 87
• FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA FAT REDUCTION MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD FROM 2023 TO 2033 88
• FIGURE 13 INCREASING DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA FAT REDUCTION MARKET GROWTH IN THE FORECAST PERIOD FROM 2023 TO 2033 89
• FIGURE 14 THE SURGICAL FAT REDUCTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA FAT REDUCTION MARKET IN 2023 & 2033 89
• FIGURE 15 ASIA-PACIFIC IS THE FASTEST-GROWING MARKET FOR THE FAT REDUCTION MANUFACTURERS IN THE FORECAST PERIOD FROM 2023 TO 2033 90
• FIGURE 16 REGISTRATION PROCESS OF THE MEDICINAL PRODUCTS INTENDED FOR HUMAN USE 147
• FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA FAT REDUCTION MARKET 160
• FIGURE 18 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY TYPE, 2022 175
• FIGURE 19 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY TYPE, 2023-2033 (USD MILLION) 176
• FIGURE 20 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY TYPE, CAGR (2023-2033) 176
• FIGURE 21 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY TYPE, LIFELINE CURVE 177
• FIGURE 22 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY APPLICATION, 2022 205
• FIGURE 23 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY APPLICATION, 2023-2033 (USD MILLION) 206
• FIGURE 24 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY APPLICATION, CAGR (2023-2033) 206
• FIGURE 25 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY APPLICATION, LIFELINE CURVE 207
• FIGURE 26 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY GENDER, 2022 216
• FIGURE 27 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY GENDER, 2023-2033 (USD MILLION) 217
• FIGURE 28 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY GENDER, CAGR (2023-2033) 217
• FIGURE 29 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY GENDER, LIFELINE CURVE 218
• FIGURE 30 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY AGE GROUP, 2022 222
• FIGURE 31 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY AGE GROUP, 2023-2033 (USD MILLION) 223
• FIGURE 32 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY AGE GROUP, CAGR (2023-2033) 223
• FIGURE 33 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY AGE GROUP, LIFELINE CURVE 224
• FIGURE 34 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY END USER, 2022 230
• FIGURE 35 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY END USER, 2023-2033 (USD MILLION) 231
• FIGURE 36 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY END USER, CAGR (2023-2033) 231
• FIGURE 37 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY END USER, LIFELINE CURVE 232
• FIGURE 38 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2022 241
• FIGURE 39 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2023-2033 (USD MILLION) 242
• FIGURE 40 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2033) 242
• FIGURE 41 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 243
• FIGURE 42 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET: SNAPSHOT (2022) 250
• FIGURE 43 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET: BY COUNTRY (2022) 251
• FIGURE 44 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET: BY COUNTRY (2023 & 2033) 251
• FIGURE 45 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET: BY COUNTRY (2022 & 2033) 252
• FIGURE 46 MIDDLE EAST AND AFRICA FAT REDUCTION MARKET: BY TYPE (2023-2033) 252
• FIGURE 47 MIDDLE EAST & AFRICA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 548
• FIGURE 48 THE SOUTH AFRICA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 549
• FIGURE 49 ABBVIE INC.IN SOUTH AFRICA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 550
• FIGURE 50 CANDELA CORPORATION CORPORATION IN SOUTH AFRICA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 551
• FIGURE 51 THE SAUDI ARABIA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 552
• FIGURE 52 ABBVIE INC.IN FRANCE FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 553
• FIGURE 53 CYNOSURE IN SAUDI ARABIA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 554
• FIGURE 54 ERCHONIA CORPORATION CORPORATION IN SAUDI ARABIA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 555
• FIGURE 55 THE UAE FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 556
• FIGURE 56 ABBVIE INC.IN UAE . FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 557
• FIGURE 57 CANDELA CORPORATION IN UAE IN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 558
• FIGURE 58 THE EGYPT FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 559
• FIGURE 59 CANDELA CORPORATION IN EGYPT FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 560
• FIGURE 60 BLACK & BLACK SURGICAL IN EGYPT FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 561
• FIGURE 61 THE KUWAIT FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 562
• FIGURE 62 CANDELA CORPORATION IN KUWAIT FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 563
• FIGURE 63 BLACK & BLACK SURGICAL IN KUWAIT FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 564
• FIGURE 64 THE ISRAEL FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 565
• FIGURE 65 ABBVIE INC.IN ISRAEL FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 566
• FIGURE 66 ALMA LASERS IN ISRAEL FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 567
• FIGURE 67 CANDELA CORPORATION IN ISRAEL FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 568
• FIGURE 68 VENUS CONCEPT IN ISRAEL FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 569
• FIGURE 69 THE ALGERIA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 570
• FIGURE 70 ABBVIE INC.IN ALGERIIA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 571
• FIGURE 71 THE JORDAN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 572
• FIGURE 72 CANDELA CORPORATION IN JORDAN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 573
• FIGURE 73 BAHRAIN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 574
• FIGURE 74 LYNTON LASERS IN BAHRAIN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 575
• FIGURE 75 BLACK & BLACK SURGICAL IN BAHRAIN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 576
• FIGURE 76 IRAN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 577
• FIGURE 77 CANDELA CORPORATION IN IRAN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 578
• FIGURE 78 HIRONIC CO LTD CORPORATION IN IRAQ FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 579
• FIGURE 79 IRAQ FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 580
• FIGURE 80 CANDELA CORPORATION IN IRAN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 581
• FIGURE 81 BLACK & BLACK SURGICAL IN IRAN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 582
• FIGURE 82 HIRONIC CO LTD CORPORATION IN IRAN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 583
• FIGURE 83 LEBANON FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 584
• FIGURE 84 ABBVIE INC.IN LEBANON FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 585
• FIGURE 85 HIRONIC CO LTD CORPORATION IN LEBANON FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 586
• FIGURE 86 LIBIYA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 587
• FIGURE 87 ADVIN HEALTHCARE IN LIBYA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 588
• FIGURE 88 MOROCCO FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 589
• FIGURE 89 ADVIN HEALTHCARE IN MOROCCO FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 590
• FIGURE 90 OMAN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 591
• FIGURE 91 CANDELA CORPORATION IN OMAN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 592
• FIGURE 92 BLACK & BLACK SURGICAL IN OMAN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 593
• FIGURE 93 QATAR FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 594
• FIGURE 94 CANDELA CORPORATION IN QATAR FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 595
• FIGURE 95 BLACK & BLACK SURGICAL IN IRAN FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 596
• FIGURE 96 TUNISIA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 597
• FIGURE 97 ABBVIE INC.IN TUNISIA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%) 598